150 related articles for article (PubMed ID: 32485209)
1. Drug screening identifies gemcitabine inhibiting rotavirus through alteration of pyrimidine nucleotide synthesis pathway.
Chen S; Wang Y; Li P; Yin Y; Bijvelds MJ; de Jonge HR; Peppelenbosch MP; Kainov DE; Pan Q
Antiviral Res; 2020 Aug; 180():104823. PubMed ID: 32485209
[TBL] [Abstract][Full Text] [Related]
2. Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation.
Li Y; Li P; Li Y; Zhang R; Yu P; Ma Z; Kainov DE; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2020 Dec; 184():104967. PubMed ID: 33137361
[TBL] [Abstract][Full Text] [Related]
3. Dasabuvir Inhibits Human Norovirus Infection in Human Intestinal Enteroids.
Hayashi T; Murakami K; Hirano J; Fujii Y; Yamaoka Y; Ohashi H; Watashi K; Estes MK; Muramatsu M
mSphere; 2021 Dec; 6(6):e0062321. PubMed ID: 34730374
[TBL] [Abstract][Full Text] [Related]
4. Modeling rotavirus infection and antiviral therapy using primary intestinal organoids.
Yin Y; Bijvelds M; Dang W; Xu L; van der Eijk AA; Knipping K; Tuysuz N; Dekkers JF; Wang Y; de Jonge J; Sprengers D; van der Laan LJ; Beekman JM; Ten Berge D; Metselaar HJ; de Jonge H; Koopmans MP; Peppelenbosch MP; Pan Q
Antiviral Res; 2015 Nov; 123():120-31. PubMed ID: 26408355
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolic acid potently inhibits rotavirus infection with a high barrier to resistance development.
Yin Y; Wang Y; Dang W; Xu L; Su J; Zhou X; Wang W; Felczak K; van der Laan LJ; Pankiewicz KW; van der Eijk AA; Bijvelds M; Sprengers D; de Jonge H; Koopmans MP; Metselaar HJ; Peppelenbosch MP; Pan Q
Antiviral Res; 2016 Sep; 133():41-9. PubMed ID: 27468950
[TBL] [Abstract][Full Text] [Related]
6. PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target.
Yin Y; Dang W; Zhou X; Xu L; Wang W; Cao W; Chen S; Su J; Cai X; Xiao S; Peppelenbosch MP; Pan Q
Virulence; 2018 Jan; 9(1):83-98. PubMed ID: 28475412
[TBL] [Abstract][Full Text] [Related]
7. Suppression of pyrimidine biosynthesis by targeting DHODH enzyme robustly inhibits rotavirus replication.
Chen S; Ding S; Yin Y; Xu L; Li P; Peppelenbosch MP; Pan Q; Wang W
Antiviral Res; 2019 Jul; 167():35-44. PubMed ID: 30974126
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activities of resveratrol against rotavirus in vitro and in vivo.
Huang H; Liao D; Zhou G; Zhu Z; Cui Y; Pu R
Phytomedicine; 2020 Oct; 77():153230. PubMed ID: 32682225
[TBL] [Abstract][Full Text] [Related]
9. Stem cell-derived human intestinal organoids as an infection model for rotaviruses.
Finkbeiner SR; Zeng XL; Utama B; Atmar RL; Shroyer NF; Estes MK
mBio; 2012; 3(4):e00159-12. PubMed ID: 22761392
[TBL] [Abstract][Full Text] [Related]
10. Cell-Based High-Throughput Screening Assay Identifies 2',2'-Difluoro-2'-deoxycytidine Gemcitabine as a Potential Antipoliovirus Agent.
Zhang Z; Yang E; Hu C; Cheng H; Chen CY; Huang D; Wang R; Zhao Y; Rong L; Vignuzzi M; Shen H; Shen L; Chen ZW
ACS Infect Dis; 2017 Jan; 3(1):45-53. PubMed ID: 27733043
[TBL] [Abstract][Full Text] [Related]
11. Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications.
Sun J; Yogarajah T; Lee RCH; Kaur P; Inoue M; Tan YW; Chu JJH
Sci Rep; 2020 May; 10(1):8159. PubMed ID: 32424333
[TBL] [Abstract][Full Text] [Related]
12. Rotavirus Infection and Cytopathogenesis in Human Biliary Organoids Potentially Recapitulate Biliary Atresia Development.
Chen S; Li P; Wang Y; Yin Y; de Ruiter PE; Verstegen MMA; Peppelenbosch MP; van der Laan LJW; Pan Q
mBio; 2020 Aug; 11(4):. PubMed ID: 32843549
[TBL] [Abstract][Full Text] [Related]
13. 6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling.
Yin Y; Chen S; Hakim MS; Wang W; Xu L; Dang W; Qu C; Verhaar AP; Su J; Fuhler GM; Peppelenbosch MP; Pan Q
Antiviral Res; 2018 Aug; 156():92-101. PubMed ID: 29920300
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel compounds against Tat-mediated human immunodeficiency virus-1 transcription by high-throughput functional screening assay.
Shin Y; Kim HG; Park CM; Choi MS; Kim DE; Choi BS; Kim K; Yoon CH
Biochem Biophys Res Commun; 2020 Mar; 523(2):368-374. PubMed ID: 31866007
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the inhibitory effects against rotavirus infection of edible plant extracts.
Knipping K; Garssen J; van't Land B
Virol J; 2012 Jul; 9():137. PubMed ID: 22834653
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of novel pyrrolopyrimidine derivatives as antiviral against gastroenteric viral infections.
Mohamed MS; Sayed AI; Khedr MA; Nofal S; Soror SH
Eur J Pharm Sci; 2019 Jan; 127():102-114. PubMed ID: 30366078
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine, a broad-spectrum antiviral drug, suppresses enterovirus infections through innate immunity induced by the inhibition of pyrimidine biosynthesis and nucleotide depletion.
Lee K; Kim DE; Jang KS; Kim SJ; Cho S; Kim C
Oncotarget; 2017 Dec; 8(70):115315-115325. PubMed ID: 29383162
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclooxygenase activity reduces rotavirus infection at a postbinding step.
Rossen JW; Bouma J; Raatgeep RH; Büller HA; Einerhand AW
J Virol; 2004 Sep; 78(18):9721-30. PubMed ID: 15331705
[TBL] [Abstract][Full Text] [Related]
19. Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids.
Hakim MS; Chen S; Ding S; Yin Y; Ikram A; Ma XX; Wang W; Peppelenbosch MP; Pan Q
Sci Rep; 2018 May; 8(1):8341. PubMed ID: 29844362
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory activities of bovine macromolecular whey proteins on rotavirus infections in vitro and in vivo.
Bojsen A; Buesa J; Montava R; Kvistgaard AS; Kongsbak MB; Petersen TE; Heegaard CW; Rasmussen JT
J Dairy Sci; 2007 Jan; 90(1):66-74. PubMed ID: 17183076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
